MS drug Sativex wins approval in 6 new markets
Posted: Tue Mar 22, 2011 7:26 am
GW Pharmaceuticals Plc's pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall.
National approvals are now expected in Austria, Czech Republic, Denmark, Germany, Italy and Sweden from mid-2011 onwards, with launches in Denmark, Germany and Sweden likely before the end of 2011, GW said on Tuesday.
The medicine was expected to go on sale in the remaining countries in 2012. ...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814